Larimar Therapeutics
LRMR
#6456
Rank
C$0.80 B
Marketcap
$11.12
Share price
-12.17%
Change (1 day)
237.11%
Change (1 year)

EPS for Larimar Therapeutics (LRMR)

EPS in 2023 (TTM): -$1.25

According to Larimar Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.29. In 2022 the company made an earnings per share (EPS) of -$2.16 an increase over its 2021 EPS that were of -$4.16.

EPS history for Larimar Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.25-42.25%
2022-$2.16-48.15%
2021-$4.16-14.27%
2020-$4.85